“…Europe and the USA have shown a sustained increased utilisation of EVAR with a continued decrease in mortality and morbidity, despite older and more comorbid patients being treated by EVAR. 7,11,[349][350][351] The contemporary 30 day mortality after elective EVAR is around 1%, compared with a three to four times higher mortality after OSR. 352,11,351 The improved short-term outcome is sustained for at least five years.…”